Klinikum der Universität München-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2024

  1. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 35, Núm. 3, pp. 248-266

  2. Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

    Bulletin du Cancer, Vol. 111, Núm. 3, pp. 277-284

2022

  1. Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: A ENYGO-IJGC Fellows initiative

    International Journal of Gynecological Cancer

2021

  1. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

2018

  1. Is there a role for HIPEC in ovarian cancer?

    Archives of Gynecology and Obstetrics